Mycophenolate mofetil Completed Phase 2 Trials for Malignancies, Hematologic Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01341301Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies